Cephalothin Cas:58-71-9

We are Cephalothin CAS:58-71-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Description:

Product Name: Cephalothin CAS NO: 58-71-9

 

Synonyms:

Cephalothin;

Cephalothin sodium salt;

7-(2-(2-thienyl)acetamido)-,acetate,monosodiumsalt;

 

Chemical & Physical Properties:

Appearance: Crystalline

Assay :≥99.00%

Boiling Point: 757.2℃ at 760 mmHg

Melting Point: 240℃

Flash Point: 411.8℃

Water Solubility: 158 mg/L

Storage Condition: 2-8℃

 

Safety Information:

RTECS: XI0388300

Safety Statements: S22; S36/37

HS Code: 3003201900

WGK Germany: 2

Risk Statements: R42/43

Hazard Codes: Xi,Xn

 

Sodium salt of Cephalothin , a first generation cephalosporin antibiotic with a wide range antibacterial activity. It is effective against gram-positive and gram-negative bacteria, and has been tested in respiratory disease and neuromuscular junction studies. Cephalothin is a first-generation cephalosporin antibiotic used to study the mechanism of liposome encapsulated antibiotics,strategies for co-opting β-lactamases of Gram-negative bacteria for treatment of antibiotics,and for immunology studies in relation to antibiotics.It is used to study the effect of expression, binding and inhibition of penicillin-binding proteins especially PBP6 on bacterial cell wall mucopeptide synthesis.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.

Market News:The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. 5-Chloro-2-methyl-4-nitroaniline manufacturer.CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. tetramisole supplier.EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. 5-(dimethoxymethyl)-1-ethylpyrazole producer.